Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus
- PMID: 30386102
- PMCID: PMC6209573
- DOI: 10.3748/wjg.v24.i40.4527
Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus
Abstract
Hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) is a disease that is not uncommon, but the treatments vary drastically between Eastern and Western countries. In Europe and America, the first line of treatment is systemic therapy such as sorafenib and the surgical treatment is not a recommend option. While an increasing number of studies from China and Japan have suggested that surgical treatment results in better outcomes when compared to transcatheter arterial chemoembolization (TACE), sorafenib, or other nonsurgical treatments, and two classification systems, Japanese Vp classification and Chinese Cheng's classification, were very useful to guide the surgical treatment. We have also found that surgical treatment may be more effective, as we have performed surgical treatment for HCC-PVTT patients over a period of approximately 15 years and achieved good results with the longest surviving time being 13 years and onward. In this study, we review the efficacy and principles of current surgical treatments and introduce our new, more effective surgical technique named "thrombectomy first", which means the tumor thrombus in the main portal vein, the bifurcation or the contralateral portal vein should be removed prior to liver resection. Thus, compression and crushing of PVTT during the operation could be avoided and new intrahepatic metastases caused by tumor thrombus to the remnant liver minimized. The new technique is even beneficial to the prognosis of Cheng's classification Types III and IV PVTT. The vital tips and tricks for the surgical approach are described.
Keywords: Hepatocellular carcinoma; Portal vein tumor thrombus; Surgery; Thrombectomy first.
Conflict of interest statement
Conflict-of-interest statement: All the authors deny any form of conflict of interest.
Figures








Similar articles
-
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.Ann Surg Oncol. 2010 Aug;17(8):2073-80. doi: 10.1245/s10434-010-0940-4. Epub 2010 Feb 4. Ann Surg Oncol. 2010. PMID: 20131013
-
New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.Surg Today. 2017 Sep;47(9):1094-1103. doi: 10.1007/s00595-017-1507-9. Epub 2017 Mar 21. Surg Today. 2017. PMID: 28324163
-
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246. World J Gastroenterol. 2015. PMID: 25574098 Free PMC article.
-
A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus.HPB (Oxford). 2018 Dec;20(12):1119-1129. doi: 10.1016/j.hpb.2018.06.1804. Epub 2018 Jul 25. HPB (Oxford). 2018. PMID: 30056066
-
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives.Hepatobiliary Pancreat Dis Int. 2024 Jun;23(3):221-227. doi: 10.1016/j.hbpd.2023.10.009. Epub 2023 Oct 22. Hepatobiliary Pancreat Dis Int. 2024. PMID: 37903712
Cited by
-
Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?World J Gastroenterol. 2022 Feb 21;28(7):704-714. doi: 10.3748/wjg.v28.i7.704. World J Gastroenterol. 2022. PMID: 35317274 Free PMC article. Review.
-
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.J Hepatocell Carcinoma. 2021 Sep 7;8:1089-1115. doi: 10.2147/JHC.S318070. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34522691 Free PMC article. Review.
-
Application of 3-dimensional visualization and image fusion technology in liver cancer with portal vein tumor thrombus surgery.Medicine (Baltimore). 2024 Jul 26;103(30):e38980. doi: 10.1097/MD.0000000000038980. Medicine (Baltimore). 2024. PMID: 39058856 Free PMC article.
-
Effect of transjugular intrahepatic portosystemic shunt combined with 125I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma.Am J Transl Res. 2022 Mar 15;14(3):1838-1848. eCollection 2022. Am J Transl Res. 2022. PMID: 35422930 Free PMC article.
-
Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi.Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821995286. doi: 10.1177/1533033821995286. Technol Cancer Res Treat. 2021. PMID: 33590809 Free PMC article.
References
-
- Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62–67. - PubMed
-
- Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–1255. - PubMed
-
- Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–390. - PubMed
-
- European Association For The Study Of The Liver. European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous